(4-Methylpiperidin-1-yl)-(3-thiophen-3-ylimidazo[5,1-a]isoquinolin-6-yl)methanone

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: (4-Methylpiperidin-1-yl)-(3-thiophen-3-ylimidazo[5,1-a]isoquinolin-6-yl)methanone
• 化学式: C₂₂H₂₁N₃OS
• 分子量: 375.5
• InChiKey: IFXABQUBELLASI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  27
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  65.8
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Bicyclic and tricyclic hetroaromatic compounds
  申请人：Neurogen Corporation, A Corporation of the State of Delaware

  公开号：US20030181455A1

  公开（公告）日：2003-09-25

  Disclosed are compounds of the formula: 1 and the pharmaceutically acceptable salts thereof, wherein W, Q, X, X 1 , Y and Z are as defined herein. These compounds bind with high selectivity and/or high affinity to the benzodiazepine site of GABA A receptors and are therefore useful in the treatment of central nervous system (CNS) diseases and as probes for the localization of GABA A receptors in tissue samples. Also disclosed are intermediates useful in the preparation of these compounds.

  本发明涉及以下式子的化合物及其药学上可接受的盐，其中W、Q、X、X1、Y和Z的定义如下。这些化合物与GABAA受体的苯二氮平位点具有高选择性和/或高亲和力，因此可用于治疗中枢神经系统（CNS）疾病，并作为探针用于定位组织样本中的GABAA受体。本发明还涉及用于制备这些化合物的中间体。
• Bicyclic and tricyclic heteroaromatic compounds
  申请人：Yuan Jun

  公开号：US20060217384A1

  公开（公告）日：2006-09-28

  Disclosed are compounds of the formula: and the pharmaceutically acceptable salts thereof, wherein W, Q, X, X 1 , Y and Z are as defined herein. These compounds bind with high selectivity and/or high affinity to the benzodiazepine site of GABA A receptors and are therefore useful in the treatment of central nervous system (CNS) diseases and as probes for the localization of GABA A receptors in tissue samples. Also disclosed are intermediates useful in the preparation of these compounds.

  本发明涉及以下式的化合物及其药学上可接受的盐，其中W、Q、X、X1、Y和Z的定义如下。这些化合物与GABAA受体的苯二氮平位点具有高度的选择性和/或高亲和力，因此在中枢神经系统（CNS）疾病的治疗中以及作为GABAA受体在组织样本中的定位探针非常有用。还公开了用于制备这些化合物的中间体。
• Bicyclic and Tricyclic Heteroaromatic Compounds
  申请人：Yuan Jun

  公开号：US20080146546A1

  公开（公告）日：2008-06-19

  Disclosed are compounds of the formula: and the pharmaceutically acceptable salts thereof, wherein W, Q, X, X 1 , Y and Z are as defined herein. These compounds bind with high selectivity and/or high affinity to the benzodiazepine site of GABA A receptors and are therefore useful in the treatment of central nervous system (CNS) diseases and as probes for the localization of GABA A receptors in tissue samples. Also disclosed are intermediates useful in the preparation of these compounds.

  本发明涉及下列公式的化合物及其药学上可接受的盐，其中W、Q、X、X1、Y和Z的定义如下。这些化合物与GABAA受体的苯二氮平位点高选择性和/或高亲和力结合，因此在中枢神经系统疾病的治疗中以及作为组织样品中GABAA受体的定位探针中有用。本发明还涉及制备这些化合物的中间体。
• BICYCLIC AND TRICYCLIC HETEROAROMATIC COMPOUNDS
  申请人：NEUROGEN CORPORATION

  公开号：EP1228069B1

  公开（公告）日：2003-04-02
• US6511987B1
  申请人：——

  公开号：US6511987B1

  公开（公告）日：2003-01-28